Targeting Astrocytes for Treatment in Amyotrophic Lateral Sclerosis

E-ISSN： 1873-4286|23|33|5037-5044

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.23, Iss.33, 2018-01, pp. : 5037-5044

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Role and Therapeutic Potential of Astrocytes in Amyotrophic Lateral Sclerosis

Current Pharmaceutical Design, Vol. 23, Iss. 33, 2018-01 ,pp. : 5010-5021

Bentham Science Publishers

Access to resources Recommend Favorite

The tolerability of riluzole in the treatment of patients with amyotrophic lateral sclerosis

By Bensimon Gilbert Doble Adam

Expert Opinion on Drug Safety, Vol. 3, Iss. 6, 2004-11 ,pp. : 525-534

Informa Healthcare

Access to resources Recommend Favorite

Amyotrophic Lateral Sclerosis: Progress and Prospects for Treatment

By Dib M.

Drugs, Vol. 63, Iss. 3, 2003-01 ,pp. : 289-310

Adis International

Access to resources Recommend Favorite

Therapeutic developments in the treatment of amyotrophic lateral sclerosis

By Jackson Mandy Lladó Jerònia Rothstein Jeffrey D

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 10, 2002-10 ,pp. : 1343-1364

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic Targeting of Epigenetic Components in Amyotrophic Lateral Sclerosis (ALS)

Current Medicinal Chemistry, Vol. 21, Iss. 31, 2014-10 ,pp. : 3576-3582

Bentham Science Publishers

Access to resources Recommend Favorite